The PI3-kinase/Akt pathway regulates many biological processes including insulinregulated GLUT4 insertion into the plasma membrane (PM). However, Akt operates well below its capacity to facilitate maximal GLUT4 translocation. Thus, reconciling modest changes in Akt expression or activity as a cause of metabolic dysfunction is complex. To resolve this we examined insulin regulation of components within the signalling cascade in a quantitative kinetic and dose response study combined with hierarchical cluster analysis. This revealed a strong relationship between phosphorylation of Akt substrates and GLUT4 translocation but not whole cell Akt phosphorylation. In contrast, Akt activity at the PM strongly correlated with GLUT4 translocation and Akt substrate phosphorylation. Additionally, two of the phosphorylated sites in the Akt substrate AS160 clustered separately, with pThr642 grouped with other Akt substrates. Further experiments suggested that aPKCζ phosphorylates AS160 at Ser588 and that these two sites are mutually exclusive. These data indicate the utility of hierarchical cluster analysis for identifying functionally related biological nodes and highlight the importance of subcellular partitioning of key signalling components for biological specificity.
The PI3-kinase/Akt pathway regulates many biological processes including insulinregulated GLUT4 insertion into the plasma membrane (PM). However, Akt operates well below its capacity to facilitate maximal GLUT4 translocation. Thus, reconciling modest changes in Akt expression or activity as a cause of metabolic dysfunction is complex. To resolve this we examined insulin regulation of components within the signalling cascade in a quantitative kinetic and dose response study combined with hierarchical cluster analysis. This revealed a strong relationship between phosphorylation of Akt substrates and GLUT4 translocation but not whole cell Akt phosphorylation. In contrast, Akt activity at the PM strongly correlated with GLUT4 translocation and Akt substrate phosphorylation. Additionally, two of the phosphorylated sites in the Akt substrate AS160 clustered separately, with pThr642 grouped with other Akt substrates. Further experiments suggested that aPKCζ phosphorylates AS160 at Ser588 and that these two sites are mutually exclusive. These data indicate the utility of hierarchical cluster analysis for identifying functionally related biological nodes and highlight the importance of subcellular partitioning of key signalling components for biological specificity.
The Receptor Tyrosine Kinase (RTKs) family is both large and diverse controlling a broad spectrum of fundamental biological processes including cell death, differentiation and proliferation. Curiously these diverse processes are controlled by a limited subset of canonical signalling modules typified by the phosphatidylinositol 3-kinase (PI3-kinase)/Akt and Ras/MAP kinase pathways. But how do relatively few signalling pathways control such a diversity of actions? In order to answer this question it is essential to identify pathway components and to understand how they interact in different cells under a range of conditions. Considerable information about the components that comprise the PI3-kinase/Akt pathway is known (1) . Activation of a RTK at the plasma membrane (PM) generates a binding site for the p85 regulatory subunit of PI3-kinase allowing for production of phosphatidylinositol-3,4,5-triphosphate (PIP 3 ) at the PM. PIP 3 serves as a docking site for proteins such as phosphoinositide-dependent kinase 1 (PDK1), and Akt that possess lipid-binding domains. This presumably concentrates Akt with its upstream regulatory kinases PDK1 and mTOR/rictor complex (2,3) resulting in Akt phosphorylation at Thr308 and Ser473 respectively. Phosphorylation at these sites leads to a regulatory conformational change in Akt that facilitates its interaction with downstream substrates. Numerous Akt substrates possessing the Akt kinase consensus motif RXRXXS/T have been identified and these have been implicated in a range of fundamental biological processes (4) .
Evidence points to a major role for Akt in almost all of insulin's metabolic actions (5) . This includes the regulation of glucose transport which is mediated via the regulated translocation of the glucose transporter 4 (GLUT4) to the PM, glycogen synthesis, protein synthesis, lipolysis and transcription. In each of these cases Akt substrates that control these processes have been identified: the RabGAP AS160/TBC1D4 (6), glycogen synthase kinase3 (GSK3) (7) , the Rheb GAP tuberous sclerosis protein 2 (TSC2) (8) , phosphodiesterase 3B (PDE3B) (9) and FoxO (10) , respectively. While many of these molecules are ubiquitous and many growth factors control the PI3-kinase/Akt pathway there are several facets of the insulin pathway that are unique: insulin regulation of metabolism is confined to muscle, adipose tissue and liver (5) ; the insulin pathway utilises the insulin receptor substrate (IRS) scaffold protein family to orchestrate upstream activation of the Akt pathway (11); and metabolism is thought to be controlled by certain signalling isoforms within the PI3-kinase/Akt pathway including the p110α PI3-kinase catalytic subunit (12, 13) and the Akt2 isoform (14-16).
Impaired insulin action or insulin resistance plays a central role in a range of metabolic diseases including Type 2 diabetes. Here it is generally considered that a defect in one or more of the upstream components of the PI3-kinase/Akt pathway results in attenuation of signal transmission through Akt leading to global dysregulation of insulin action. For example, a modest reduction in tyrosine phosphorylation of IRS1 will lead to a modest reduction in PI3-kinase activation in turn leading to a modest reduction in Akt activation and so on. This implies the existence of a robust coupling mechanism between each of the components that define the system. One prediction from this is that each of the components that comprise a functionally related node will exhibit behavioural kinship that should be measurable. However, we have recently observed features of the Akt node that do not support this hypothesis. Biological outputs such as GLUT4 translocation achieve a maximal stimulatory level at insulin concentrations that are sufficient to activate as little as 10-20% of the total cellular Akt pool (17, 18) . Thus this implies that Akt operates well below its maximal capacity. Under physiological conditions, most processes have evolved to operate over the steepest and most responsive part of their intrinsic range. However, this appears not to be the case for Akt. Intuitively, it is difficult to envisage how minute changes in Akt activity could accurately translate into large biological changes of the kind observed for GLUT4 translocation and so on. Consistent with this anomalous behaviour we recently observed that in a range of insulin resistance models while defects in Akt activity were in some cases evident there was little parity between this and phosphorylation of other substrates such as the AS160 or GLUT4 translocation (17) . In the present study we set out to investigate the topology of a range of components within the insulin signalling network in order to test the behavioural kinship hypothesis. We found that a simple dose response analysis provided a powerful behavioural index of individual components. Hierarchical cluster analysis allowed us to sort components into related groups providing the first clue that Akt phosphorylation at either Thr308 or Ser473 in whole cells maintains a poor relationship with insulin dependent phosphorylation of a range of Akt substrates including AS160, GSK3, FoxO, and TSC2. In contrast, there was a strong relationship between Akt phosphorylation at the PM with GLUT4 translocation and AS160 phosphorylation at its major 14-3-3 binding site Thr642. Interestingly among the Akt substrates, AS160 is clustered closest to GLUT4 translocation. This is striking since AS160 but none of the other substrates has been implicated as a major regulator of GLUT4 translocation. Hence, these studies support a model of behavioural kinship suggesting that similar analyses might be useful in mapping functional signalling nodes within complex networks. Our studies also show that subcellular localisation of signalling components is likely one of the major determinants of specificity and so in terms of mapping mechanistic disease loci this may represent a major target.
EXPERIMENTAL PROCEDURES
Materials-Polyclonal rabbit antibodies raised against total Akt, pThr308 Akt, total GSK3β, pSer21/9 GSK-3α/β, pThr389 S6 kinase, pSer256 FoxO1, pThr1462 TSC2, and monoclonal rabbit antibodies raised against pSer473 Akt (193H12) (for immunofluorescence), GAPDH, phospho-Akt substrate (PAS), and phospho-(Ser) PKC substrate, and mouse monoclonal antibody raised against pSer473 Akt (for western blot) and pThr202/Tyr204 MAP kinase were purchased from Cell Signaling Technologies (Beverly, MA). Polyclonal rabbit antibodies raised against TSC2, FoxO1 and 14-3-3β were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Polyclonal AS160 antibody was from Upstate Biotechnology (Lake Placid, NY) and monoclonal HA antibody was from Covance (Berkeley, CA). The mouse monoclonal antibodies raised against Crk and caveolin were from Transduction Laboratories (Lexington, KY Immunoprecipitates were washed extensively and kept in 2x SDS sample buffer at -20˚C. Subcellular Fractionation-After stimulation with insulin, 3T3-L1 adipocytes were washed with ice-cold PBS and harvested in ice-cold HES buffer (20 mM HEPES pH7.4, 1 mM EDTA, 250 mM sucrose) containing Complete protease inhibitor mixture and phosphatase inhibitors (2 mM sodium orthovanadate, 1 mM sodium pyrophosphate, 10 mM sodium fluoride). The cells were lysed with 12 passes through a 22-gauge needle and 6 passes through a 27-gauge needle. Cell lysates were then centrifuged at 500 x g for 10 min at 4˚C to remove unbroken cells. The supernatant was centrifuged at 10,080 x g for 20 min at 4˚C to yield two fractions: the pellet fraction consisting of plasma membranes (PM) and mitochondia/nuclei (M/N), and the supernatant fraction consisting of cytosol, low density microsomes (LDM), and high density microsomes (HDM). The supernatant was then centrifuged at 15,750 x g for 20 min at 4˚C to obtain the pellet HDM fraction. The supernatant was again centrifuged at 175,000 x g for 75 min at 4˚C to obtain the cytosol fraction (supernatant) and the LDM fraction (pellet). To obtain PM fraction, pellet from the first ultracentrifuge spin was resuspended in HES buffer containing phosphatase and protease inhibitors and layered over high sucrose HES buffer (20 mM HEPES pH7.4, 1 mM EDTA, 1.12 M sucrose) and centrifuged at 78,925 x g for 60 min at 4˚C. The PM fraction was collected above the sucrose layer and the pellet was the M/N fraction. All the fractions were resuspended in HES buffer containing phosphatase and protease inhibitors. Protein concentration for each fraction was performed using BCA assay. Samples were made up in SDS sample buffer and then kept at -20˚C. Lipid Raft Preparation-Following stimulation with insulin, 3T3-L1 adipocytes were washed with ice-cold PBS. Cells were harvested in icecold MES buffer (25 mM MES pH6.0, 150 mM NaCl) containing Complete protease inhibitor mixture and phosphatase inhibitors (2 mM sodium orthovanadate, 1 mM sodium pyrophosphate, 10 mM sodium fluoride) and lysed with 12 passes through a 22-gauge needle and 6 passes through a 27-gauge needle at 4˚C. Cell lysates were then centrifuged at 500 x g for 10 min at 4˚C to remove unbroken cells. The pellet was discarded and the supernatant was solubilised with Triton-X 100 in a final concentration of 1% on ice for 60 min. Following solubilisation, the lysate was centrifuged at 18, 000 g for 15 min at 4˚C. The supernatant collected was the Triton-soluble fraction. The pellet, which is the Tritoninsoluble fraction, was washed with MES buffer and then resuspended in MES buffer containing 1% SDS. Protein concentration was determined with BCA assay and samples were made up in SDS sample buffer and kept at -20˚C. Quantitative GLUT4 Translocation Assay-HA-GLUT4 translocation to the plasma membrane was measured as described previously (22) . Briefly, 3T3-L1 adipocytes stably expressing HA-GLUT4 in 96-well plates were starved for 2 h in serum-and bicarbonate-free DMEM containing 20 mM HEPES (pH 7.4) and 0.2% BSA. After stimulation, cells were fixed and immunolabelled with monoclonal anti-HA antibody followed by Alexa488-labeled secondary antibody in the absence or presence of saponin to analyse the amount of HA-GLUT4 at the plasma membrane or the total HA-GLUT4 content, respectively. Confocal Laser Scanning Microscopy-3T3-L1 fibroblasts were seeded and differentiated into adipocytes on glass coverslips. Cells were serum-starved for 2 h at 37°C before stimulation with indicated doses of insulin for 20 min. For some experiments, cells were pre-treated with 10 µM Akti or 0.1% DMSO for 15 min before insulin stimulation. After stimulation, cells were washed in ice-cold PBS, fixed with 3% paraformaldehyde and quenched with 50 mM glycine. Cells were then blocked and permeabilised in 2% BSA and 0.1% saponin in PBS and labelled for activated Akt using rabbit monoclonal pSer473 Akt antibody. Primary antibody was detected with anti-rabbit Cy2-conjugated secondary antibody. Optical sections were obtained through scans for Cy2 using the Leica TCS SP confocal laser scanning microscope using a 63x 1.32 oil lens. For quantification, random images of pSer473 Akt at the base of the cells were collected with the same confocal settings. Images were analysed using the Region detector software and the mean fluorescence was measured. Fixed Cell Total Internal Refection Fluorescence (TIRF) Microscopy-3T3-L1 adipocytes were seeded in cloning rings attached on 42mm coverslips. Following stimulations, cells were fixed with 3% paraformaldehyde and quenched with 50 mM glycine. Cells were then blocked and permeabilised in 2% BSA and 0.1% saponin in PBS and labelled for activated Akt using rabbit monoclonal pSer473 Akt antibody. Primary antibody was detected with anti-rabbit Alexa488-conjugated secondary antibody. Cells were imaged in PBS containing 5% glycerol and 2.5% DAPKO as previously described (23) using a Zeiss Axiocam MRm. Cells were randomly selected by brightfield illumination prior to TIRF imaging and images were analysed with Image J software. Modelling-The data from the experiments was quantified and normalised relative to the maximal (long time or maximal dose) response. All data from all experiments was combined as a single data set to be fitted using nonlinear regression to obviate the need to weight the different time/dose points.
Time courses were fitted to a single exponential rise,
where t is time, y is the level of the phosphorylation relative to the long-term level, p is the initial value of phosphorylation (again relative to the long-term level) and K is the rate. The half time of the process was also determined as .
The dose response data were fitted to a logistic curve,
, where x is the dose, a is the initial (zero dose) phosphorylation level, relative to the maximal (infinite dose) phosphorylation level, and r is the rate. The dose at which the half-maximal response is observed, ED50, is defined as
Hierarchical clustering was performed across either the dose variables, r, ED50 and a, the temporal variables, K, H and p, or both to group the different components. The values of the variables were normalised, converting all values in the data set to use the same proportional scale, with zero mean and standard deviation of one. The distance between every pair of components in the data set, the dissimilarity matrix, was determined. For this study a "city-block" metric was employed, such that the distance between components r and s was defined as of components r and s respectively, and n is the total number of variables over which clustering is determined. The dissimilarity matrix was then analysed to create a hierarchical cluster tree. The distance from one cluster of objects to another cluster of objects was defined as the unweighted average of the distances between individual objects in different clusters. Ultimately in hierarchical clustering, all clusters are combined.
We then determined where to cut the hierarchical tree into clusters, either by determining a maximum distance separating members of a single cluster or alternatively specifying the number of clusters.
Statistical Analysis-Data are expressed as means ± standard deviation (SD). p values were calculated by two tailed Student's t test using Microsoft Office Excel 2003.
RESULTS

Dose and kinetic characteristics of Akt signalling in 3T3-L1 adipocytes-Given that
Akt is necessary and sufficient in mediating GLUT4 translocation, one would expect to see a strong relationship between GLUT4 translocation and Akt phosphorylation. However as illustrated in Fig. 1 , we observed a poor relationship between insulin-regulated HA-GLUT4 translocation and total cellular Akt phosphorylation in 3T3-L1 adipocytes. This is most clearly represented by the difference in the ED50, the dose which produces 50% of the maximal response, defining its sensitivity, and r, the dose rate constant, a measure of the dynamic range of the response (Supplementary Table 1 ), which were found by fitting the data (see Experimental Procedures). We next wanted to determine if this shift in the behaviour of Akt with respect to one of its major biological targets, GLUT4, is an intrinsic feature of all components in the insulin signalling network. Alternatively, this may underpin a switch like behaviour of Akt or it may indicate that Akt is not the major regulator of insulin regulated GLUT4 translocation. To test this we selected a range of components in the insulin signalling cascade including phosphorylation of Akt at Thr308 and Ser473, putative Akt substrates (pSer9 GSK3, pThr642 AS160, pSer588 AS160, pThr1462 TSC2), substrates located further downstream of Akt (pThr389 S6 kinase) or a substrate that is located on a separate branch of the insulin signalling network (p42/p44 MAP kinase), as shown in Fig. 2 . These phospho sites represent key regulatory sites in each of these molecules and so this should provide a sensitive index of the activity of each component. Phospho specifc antibodies as well as antibodies against non-phosphorylated sites against each of these components were either produced in house or obtained from commercial sources and were highly specific for their respective targets in 3T3-L1 adipocytes (see Fig. 3 ).
Comparison of the dose response curves for each of these components revealed that the ED50 (see Experimental Procedures) for insulinstimulated Akt phosphorylation was of the order of 6 nM while the ED50 for insulin-stimulated Akt (25) . Notably, phosphorylation of Thr389 S6 kinase, p42/p44 MAP kinase and Ser588 AS160 were very slow and in some cases not even showing a significant response until 5 min of insulin stimulation. However, unlike that observed for the dose response studies, the time course of phosphorylation of Akt at both Thr308 and Ser473 was more akin to the Akt substrates (Figs. 3C & 3D, and Supplementary Table 1) . Hence, this suggests that time course of response and dose response analyses yield discrete behavioural aspects of signalling components. Nevertheless time course data clearly resolved discrete behavioural differences particularly between different Akt substrates. We next wanted to examine the possibility that this temporal behaviour was unique to insulin stimulation or a more generic feature of the signalling pathway per se. A distinguishing feature of the insulin receptor compared to other growth factor receptors is that it utilises IRS1 as a scaffold to recruit and activate PI3-kinase whereas the PDGFR does so directly, bypassing IRS1 (see Fig. 2 ). Hence, we next engineered 3T3-L1 adipocytes to overexpress the PDGFR facilitating PDGF-dependent activation of GLUT4 translocation to a similar extent to that seen with insulin (data not shown). The time courses of the phosphorylation of the different components in response to insulin and PDGF are shown in Figs. 3C & 3D .
We next wanted to analyse these findings using a quantitative approach. As described in Experimental Procedures, firstly, the dose response curves were fitted to obtain the dose response variables -the ED50, the rate, r, and the basal phosphorylation level, a and the time courses were fitted to obtain the temporal variables -half time, the rate, k, and the initial phosphorylation level, p, (Supplementary Table  1) . These variables were then used to determine the relative similarity of the different components using hierarchical clustering (see Experimental Procedures). If we restricted the clustering to only the dose response variables, then two major clusters were formed (Fig. 4A ), which were consistent with the qualitative observations of the data above. The first cluster was comprised of the Akt substrates (pThr642 AS160, pSer9 GSK3, pSer256 FoxO and pThr1462 TSC2) together with HA-GLUT4 translocation. The second cluster was comprised of pThr308 Akt, pSer473 Akt, p42/p44 MAP kinase, pSer588 AS160 and pThr389 S6 kinase. If both dose response and temporal variables were used, this relationship was not significantly altered (Fig. 4B) , indicating that the major features of these distinct clusters are dominated by the dose response behaviour. Hierarchical clustering of the dynamic response to insulin using the temporal variables alone segregated the components into two major clusters (with two outliers) (Fig. 4C) . However, the two clusters were not identical to that achieved using the dose response variables, as indicated in Fig.  4A . The Akt substrates that fell into a single cluster using dose response variables were widely distributed among all clusters using temporal variables (as indicated by the colour coding in Fig. 4C ). Temporal variable clustering is, however, useful when comparing the response of the system to different types of stimuli, for instance to insulin and PDGF. Comparing the temporal clustering of the response to PDGF (Fig. 4D) to that of insulin (Fig. 4C) we observed a similar distribution of signalling components, with the only notable exception being pThr1462 TSC2. This suggests that the temporal behaviour of the signalling components is embedded within the canonical PI3-kinase/Akt network and independent of IRS1.
Insulin dose response of active Akt on the plasma membrane.-The data described above indicate that the temporal and dose characteristics of Akt substrate phosphorylation are a better predictor of biological outcome, in this case GLUT4 translocation, than phosphorylation of the total cellular pool of Akt (Fig. 4B) . This implies that Akt phosphorylation at least as measured here, is lacking one or more key regulatory features of kinase activity in vivo. Recent evidence suggests that subcellular location may be an important determinant of Akt specificity (26, 27 ) and so we next utilised morphological and biochemical methods to dissect this aspect of Akt function. Confocal (Fig. 5A ) and total internal reflection fluorescence (TIRF) (Fig. 5B ) microscopy revealed that in response to insulin there was a significant increase in Akt phosphorylation at the PM in 3T3-L1 adipocytes. This labelling was specific being inhibited by the specific Akt inhibitor Akti-1/2 (Figs. 5C & 5D) . Notably measurement of Akt phosphorylation at the PM using either confocal or TIRF microscopy at different insulin concentrations revealed a very different pattern to that observed for Akt phosphorylation measured biochemically in whole cell lysates (Fig. 5E) . Hierarchical clustering over the dose variables revealed that Akt phosphorylation spatially confined to the PM behaved like GLUT4 translocation and pThr642AS160 phosphorylation and was found in a separate cluster to total cellular Akt phosphorylation (Fig. 5F) .
A highly phosphorylated pool of AS160 on the plasma membrane-The clustering data described above made several predictions about the topology of the Akt network. First, the highly significant relationship between Akt activation at the PM and the phosphorylation of several key downstream targets including AS160 raises the possibility that phosphorylation of these substrates occurs at the PM. Second, the relatively poor relationship between Akt phosphorylation of the same substrate AS160 at two separate sites (Thr642 and Ser588) suggests a non-uniformity in access of Akt to distinct domains within this molecule that are not immediately evident from published data (24,28). To further investigate these issues we employed a biochemical approach involving a well-established subcellular fractionation protocol to study the compartmental organisation of Akt together with its substrates. The majority of insulin-stimulated phospho Akt was found in the cytosol with lower levels identified in membrane fractions (HDM, LDM, PM and M/N) (Fig. 6A) . The specific activity of phospho Akt was highest in the PM fraction (Fig. 6B) . These data are consistent with the morphological data showing that there is a pool of active Akt enriched in the PM (Fig. 5) . Insulin-stimulated pThr642 AS160 was also highly enriched in the PM suggesting that this is likely the site where this substrate is both phosphorylated by Akt and possibly where it mediates its principal function. Consistent with previous data (21), the majority of immunoreactive AS160 was in the LDM fraction both in the absence and presence of insulin (Fig.  6A) suggesting that a relatively small pool of this protein is phosphorylated at Thr642 even in response to maximum insulin stimulation. To confirm this observation we next performed immunoprecipitation using the anti pThr642 AS160 antibody (Fig. 7A ). This resulted in efficient isolation of the pThr642 form of the AS160 as indicated by the fact that the flow through fraction was almost completely depleted of this antigen. However, a large proportion of immunoreactive AS160 was found in the flow through consistent with the fact that a relatively small pool of AS160 is phosphorylated at the Thr642 site (Fig. 7A) . Surprisingly, the majority of insulin-stimulated pSer588 AS160 was also found in the flow through indicating that phosphorylation at pThr642 and pSer588 is mutually exclusive. This was reminiscent of our cluster analysis described above (Fig. 4A) where insulin-dependent phosphorylation of AS160 at Ser588 was found in a discrete cluster from all other Akt substrates. Intriguingly, the dose response cluster analysis placed AS160 Ser588 phosphorylation closest to S6 kinase phosphorylation than to any other signalling component (Fig. 4A) . Hence, we next tested the hypothesis that mTOR or S6 kinase may phosphorylate AS160 at Ser588 in vivo using the mTOR inhibitor rapamycin and other kinase inhibitors. Whereas the specific Akt inhibitor Akti-1/2 blocked AS160 Ser588 phosphorylation, no inhibition was observed with rapamycin, in contrast to S6 kinase phosphorylation that is blocked by both inhibitors (Supplementary Fig. 1 ).
Based upon the differential clustering between pSer588 AS160 and other Akt substrates (Fig. 4A) we reasoned that phosphorylation at Ser588 may be regulated by an alternate kinase. Because atypical PKC's have been implicated in insulin action downstream of PI3-kinase (29) we tested the hypothesis that they may regulate AS160 Ser588 phosphorylation. As shown in Fig. 7B , we observed direct interaction between PKCζ (PKCζ Α119E dominant active; PKCζ KW dominant negative) and AS160 as well as PKCζ-dependent phosphorylation of AS160. Intriguingly, mutation of the Ser588 site but not mutation at other insulin-regulated sites on AS160 (24) resulted in almost complete abolition of PKCζ-mediated phosphorylation of AS160 (Figs. 7B & 7C) , whereas the interaction between these proteins was unaffected (Fig. 7B) . Moreover, mutation of the Ser588 site alone resulted in a similar loss of binding to the phosphoSer PKC substrate antibody as that seen for the 4P AS160 mutant in which all four insulin regulated phosphorylation sites have been mutated (24) (Figs. 7B & 7C) . Taken together, these data indicate that a minority of the AS160 pool is phosphorylated on Thr642 upon maximum insulin stimulation and that this pool is distinct from that phosphorylated at Ser588.
Concentration of insulin signalling in detergent insoluble rafts-The PM is a heterogenous organelle being comprised of lipid raft and non-raft domains (30) . Some reports have suggested that lipid rafts represent signalling subdomains and so we next examined the distribution of the insulin signalling pathway within these subdomains. Rather than isolate PM from 3T3-L1 adipocytes prior to separation of raft domains potentially running the risk of disrupting the architecture of these structures we opted to use a more rapid method involving detergent insolubility. This relatively simple fractionation method was effective at isolating lipid rafts as indicated by the enrichment of caveolin, a marker for lipid rafts, in the Tx insol fraction and enrichment of the cytosolic proteins 14-3-3β and Crk in the Tx sol fraction (Fig. 8A) . The specific activity of pSer473 Akt and pSer9 GSK3 were similar in these two fractions. However, both pThr642 AS160 and pSer588 AS160 were highly enriched in the Tx insol fraction, but in contrast to pSer588 AS160, pThr642 AS160 was almost undetectable in the Tx sol fraction (Figs. 8A & 8B) . This data shows firstly that pThr642 AS160 is localised differently to other Akt substrates (Fig. 8 & data not shown) and secondly that there are distinct pools of AS160, highlighting the crucial role of compartmentalisation in signal transduction.
DISCUSSION
Hierarchical clustering of the canonical PI3-kinase/Akt pathway in 3T3-L1 adipocytes using dose and temporal variables reveals several novel topological features of this network. Firstly, Akt substrates including TSC2, GSK3, AS160 and FoxO belonged to a distinct cluster that could be segregated from non-Akt substrates such as S6 kinase and p42/p44 MAP kinase. Second, a disparity was observed between phosphorylation of a range of Akt substrates and Akt itself and this was resolved by considering the spatial localisation of active Akt, implicating an important role for Akt at the PM. Third, Akt phosphorylation at the PM was highly clustered with AS160 phosphorylation at Thr642 as well as with GLUT4 translocation providing independent evidence for a functional link between these components. Finally, phosphorylation of AS160 at an alternate putative Akt site, Ser588 did not cluster with Thr642 phosphorylation nor with other Akt substrates suggesting that this is not an Akt substrate. Further functional studies revealed that Ser588 in AS160 is a substrate of aPKCζ and that phosphorylation at the Ser588 and Thr642 sites is mutually exclusive suggesting a sequential mode of regulation.
The starting point for these studies was that the ED50 for insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes was significantly less than that of insulin-stimulated Akt activation. This did not fit with the concept that the Akt pathway is necessary and sufficient for this particular biological action of insulin because if this were the case one would predict direct transmission between individual pathway components and thus a more predictable behaviour of the pathway as a whole. This was borne out in analysis of a group of Akt substrates, which elicited behaviour more analogous to GLUT4 translocation than to Akt phosphorylation itself. This discrepancy at the Akt node was resolved with the realisation that Akt displays spatially restricted behaviour in that Akt phosphorylation at the PM, but not in the whole cell lysate, was highly correlated with GLUT4 translocation. It is perhaps not surprising that a functional pool of Akt resides at the PM since this is where the enzyme is activated. As to whether this reflects preferential localization of a particular Akt isoform to the plasma membrane, as recently suggested by McGraw and colleagues (31) will require further study. The observation that Akt phosphorylation at the PM is highly clustered with the phosphorylation of several Akt substrates raises the possibility that phosphorylation of these substrates may well occur at the PM or another restricted compartment. This conclusion was supported by subcellular fractionation studies, which showed an enrichment of the phospho Akt substrates in the PM fraction. Consistent with the PM as a central location of the Akt node, it has been shown that selective targeting of Akt to the PM (32, 33) , results in Akt activation concomitant with robust GLUT4 translocation and phosphorylation of AS160, GSK3 and S6 kinase.
Cluster analysis of multi site phosphorylation of AS160 further exemplified the utility of this approach for dissecting novel features of signalling pathways. Whereas phosphorylation of AS160 at Thr642 was highly clustered with GLUT4 translocation this was not the case for another putative Akt site at Ser588. Further analysis revealed that phosphorylation of AS160 at Ser588 is probably regulated by aPKCζ and not by Akt directly, and phosphorylation at Ser588 and Thr642 is mutually exclusive. This raises the possibility that AS160 regulation is more complex than previously realised involving either a multi site phosphorylation cascade or two functionally distinct pools of AS160. Phosphorylation of Thr642 on AS160 is important for 14-3-3 binding and GLUT4 trafficking (20) , and many agonists that regulate GLUT4 translocation induce phosphorylation at this site (28) . On the other hand, this was not the case for Ser588 and the importance of Ser588 phosphorylation is still not well understood (28) . It should also be noted that AS160 possesses several other regulated phosphorylation sites (34) that require more detailed analysis.
Despite the fact that the Akt substrates do cluster based on dose response and time course variables, it was of interest that taking dose response alone into account, which tends to dominate this relationship, then among the four Akt substrates studied, the strongest link to GLUT4 translocation was with AS160. This is striking in view of the known role of AS160 in GLUT4 trafficking in 3T3-L1 adipocytes (21, 24) . In contrast, FoxO, TSC2 and GSK3 regulate transcription, protein synthesis and glycogen synthesis, respectively (4). Thus it is of interest to discern other unique features of AS160 regulation that distinguish it from these other substrates. First, the specific activity of pThr642 AS160 in the PM was considerably higher than that of other substrates. Second, within the PM, pThr642 AS160 was confined to a detergent insoluble subdomain as was a limited pool of active Akt. Finally, the stoichiometry of AS160 phosphorylation at pThr642 was very low with the majority of the protein being found in the LDM fraction. These observations highlight the fact that unlike other Akt substrates such as FoxO, insulin regulation of AS160 is confined to a very discrete subpopulation of AS160 molecules. These data raise novel insights into the process as well as new questions concerning AS160 regulation. Previously it was thought that AS160 functions by binding to intracellular GLUT4 vesicles in the absence of insulin and inhibiting a Rab required for GLUT4 trafficking with its Rab GTPase activating protein (RabGAP) domain (21) . Insulin-dependent phosphorylation of AS160 was suggested to inhibit its RabGAP activity, thus promoting Rab GTP loading and GLUT4 trafficking (21, 24) . In this model, however, there is no a priori role for AS160 at the PM. Based on the current data we feel it is necessary to consider an alternate model where the major functional pool of AS160 resides in a specific location within the PM. This localisation may serve to bring AS160 into proximity of a discrete pool of active Akt and possibly other molecules such as the putative Rab substrate. In this model, phosphorylation of AS160 may not only affect the RabGAP activity of AS160 but also its ability to act as an effector for vesicle docking and fusion with the PM, an event that might ultimately be linked to its GAP activity in order to recycle the components that underpin this process. It will be of interest to determine how AS160 and Akt are targeted to the discrete PM subdomain and as to whether these proteins form a complex at this site. Recent studies have identified Akt-binding proteins that may serve such a function. These include APPL1 (35) and ClipR-59 (27) both of which have been implicated in insulin action and GLUT4 trafficking. It is however clear from the current work that the regulation of AS160 by Akt and that of other Akt substrates is distinct which is consistent with the possibility that different Akt binding proteins selectively tether the kinase to unique substrates. For example, endosomal partitioning of Akt by APPL1, appears to control phosphorylation of GSK3 but not TSC2 (36) . In contrast, targeting of Akt to lipid rafts controls the phosphorylation of a different subset of substrates (26) .
These studies validate the prediction that functionally linked intermediates in complex signal transduction networks display highly related behaviour. This behaviour can be mapped based upon analysis of a relatively simple set of variables that include the dose response relationship and the kinetics of the response. By subjecting such data to hierarchical cluster analysis it is feasible to make novel predictions about the topology and composition of signalling pathways. The current studies support the emerging concept that subcellular localisation plays a central role in determining the sensitivity, specificity and kinetics of signalling which may skew interpretation of studies that have overlooked this parameter. In this context, we found that the dose response of Akt activation at the PM but not in the whole cell lysate correlates with GLUT4 translocation. Further studies are required to identify alternate Akt substrates in the PM that could play an important role in this process. These findings bring us a step closer to understanding the physiology of insulin action and how it might go awry. The abbreviations used are: PM, plasma membrane; PIP 3, phosphatidylinositol-3,4,5-triphosphate; PDK1, phosphoinositide-dependent kinase 1; GSK3, glycogen synthase kinase3; TSC2, tuberous sclerosis protein 2; PDE3B, phosphodiesterase 3B; IRS, insulin receptor substrate; GLUT4, glucose transporter 4. Inset is the total cell lysates of 3T3-L1 adipocytes immunoblotted with antibodies against pSer473 Akt and total Akt. E. Insulin dose response of pSer473 Akt from the TCL, IF-PM, and TIRFM-PM expressed as a maximum response of 100 nM insulin stimulation. Results are displayed as means ± S.D. F. Clustering of insulin response over dose variables for signalling components from the TCL (pThr308Akt, pSer473 Akt, Ser588 AS160, and Thr642 AS160), pSer473 (IF-PM), pSer473 (TIRFM-PM), and HA GLUT4 (PM). Note that while pSer588 AS160 is clustered with the TCL Akt components, pThr642 AS160 clusters with both the Akt components at the PM as well as HA GLUT at the PM. Fig. 6 . Phosphorylated AS160 is concentrated at the plasma membrane. A. 3T3-L1 adipocytes were serum-starved for 2 h and treated with 10 nM insulin for 20 min. Cells were then fractionated to obtain different subcellular fractions, total cell lysates (TCL), cytosol, high-density microsomes (HDM), low-density microsomes (LDM), plasma membranes (PM), and mitochondria/nuclei (M/N). Fractions were then subjected to western blot analysis with pSer473 Akt, total Akt, pThr642 AS160, total AS160, IRAP, GLUT4, GAPDH, and 14-3-3β antibodies. B. Quantification of panel A. Specific activity of pSer473 Akt and pThr642 AS160 from various fractions normalised against insulin stimulation of the TCL. Fig. 7 . Differences in phosphorylation in Ser588 and Thr642 on AS160. A. 3T3-L1 adipocytes were serum-starved for 2 h and treated with 100 nM insulin for 20 min. Cell lysates were prepared and Thr642 phosphorylated AS160 was immunoprecipitated with specific pThr642 AS160 rabbit antibody. A non-immunised rabbit IgG (CT) was used as control for immunoprecipitation using 
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